Bronchial Asthma

- Research gaps

1.  “SABA over-reliance in Egyptian asthma care: prevalence, drivers and outcomes across the three tiers of care.”

2.  “Real-world effectiveness, availability and cost-effectiveness of ICS-formoterol as anti-inflammatory reliever / MART versus SABA-based regimens in Egyptian patients.”

3.  “Phenotyping difficult-to-treat and severe asthma in a resource-limited setting: accessible biomarkers (blood eosinophils ± FeNO) as predictors of biologic eligibility in an Egyptian multicenter cohort.”